Geron Corporation
Geron Corporation develops medicines for blood cancers, focusing on myeloid hematologic malignancies and utilizing telomerase inhibition as a treatment strategy.
Specifications
- LocationCalifornia, USA
- Industry Role
- Content Platform
- Colors